Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (Epinephrine) Injection for Potential Manufacturing Defect

Medication SafetyHealthcare Professional

Mar 23

Written By Denise Kolakowski

Recalled due to the potential clogging of the needles.

Learn more form the FDA

Denise Kolakowski

Sandoz, Inc. Issues Nationwide Recall of 13 Lots of Orphenadrine Citrate 100 mg Extended Release Tablets Due to Presence of a Nitrosamine Impurity

National Drug and Alcohol Facts Week 2022: Guest Blog from the Michigan Poison and Drug Information Center for Wayne Health